Last updated: 2026-10-12 23:35:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Solventum Corporation (SOLV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $85,37, with a market capitalization of $14,86B and a P/E ratio of 10,36. Over the past 52 weeks, its price has ranged from $62,38 to $94,16. This page covers its latest market performance, valuation, price trends and company information.
$14,86B | |
$87,00 | |
$94,16 | |
$47,16 | |
$87,29 | |
1,14M | |
1,04M | |
10,36 | |
$94,16 | |
$62,38 | |
-- | |
-- |
Solventum Corporation (SOLV) is trading at $85,37 in after-hours trading as of 2026-10-12 23:31:00, down 2,21% ($1,93) from the regular-session close of $87,29.
After-hours trading shows how investors are pricing SOLV after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Solventum Corporation (SOLV) moved from $87,77 to $85,37, representing a decline of 2,74% ($2,40).
The stock traded between $84,55 and $89,03 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 993,55 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 72,3%
SOLV is currently trading at $85,37, placing it 72,3% of the way from its 52-week low of $62,38 to its 52-week high of $94,16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 20000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Solventum Corporation (SOLV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.